Condition: Subdural Hematoma · Sponsor: University of Manitoba
EMMA-Can is a prospective cohort study to assess the safety and effectiveness of MMA-embolization for the treatment of CSDH. Hypothesis- EMMA reduces the recurrence rate of CSDH with or without concomitant surgical evacuation.
This description comes directly from the study's public registry record.
Jai Shankar, MD · 4313734164 · shivajai1@gmail.com
Susan Alcock, RN · 2047893669 · susan.alcock@umanitoba.ca
Always discuss trial participation with your own doctor first.
| Health Sciences centre | Winnipeg MB, Manitoba, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04923984